Bessemer Group’s Harmony Biosciences HRMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$20K Sell
505
-25
-5% -$966 ﹤0.01% 1989
2026
Q2
$20K Sell
530
-25
-5% -$789 ﹤0.01% 1999
2026
Q1
$16K Buy
555
+318
+134% +$10.4K ﹤0.01% 1993
2025
Q4
$9K Buy
237
+16
+7% +$526 ﹤0.01% 2132
2025
Q3
$6K Buy
221
+50
+29% +$1.72K ﹤0.01% 2091
2025
Q2
$6K Buy
171
+4
+2% +$129 ﹤0.01% 1970
2025
Q1
$6K Buy
167
+46
+38% +$1.65K ﹤0.01% 1954
2024
Q4
$4K Sell
121
-31
-20% -$1.06K ﹤0.01% 2068
2024
Q3
$6K Buy
152
+66
+77% +$2.32K ﹤0.01% 1856
2024
Q2
$3K Hold
86
– – ﹤0.01% 1848
2024
Q1
$3K Sell
86
-125
-59% -$4.01K ﹤0.01% 1851
2023
Q4
$7K Buy
211
+18
+9% +$502 ﹤0.01% 1670
2023
Q3
$6K Buy
193
+158
+451% +$5.48K ﹤0.01% 1703
2023
Q2
$1K Buy
+35
New +$1.21K ﹤0.01% 2163
2022
Q2
– Sell
-93
Closed -$5K – 1936
2022
Q1
$5K Hold
93
– – ﹤0.01% 1513
2021
Q4
$4K Hold
93
– – ﹤0.01% 1642
2021
Q3
$4K Hold
93
– – ﹤0.01% 1537
2021
Q2
$3K Hold
93
– – ﹤0.01% 1476
2021
Q1
$3K Buy
+93
New +$3.26K ﹤0.01% 1433

Other funds holding HRMY

Bessemer Group's HRMY Position: Q3 2026 in Review

Bessemer Group reduced its Harmony Biosciences (HRMY) stake by 4.7% in Q3 2026, selling an estimated $966 and leaving 505 shares worth $20K. The position accounts for ﹤0.01% of the portfolio, ranked #1989.

Bessemer Group first reported a position in HRMY in Q1 2021 and has held it in 19 quarters since. 358 funds tracked by Wall St. Rank hold HRMY as of Q3 2026.

  • Bessemer Group held 505 shares of Harmony Biosciences worth $20K as of Q3 2026.
  • Bessemer Group sold 25 Harmony Biosciences shares in Q3 2026, an estimated $966.
  • Harmony Biosciences made up ﹤0.01% of Bessemer Group's portfolio in Q3 2026, its #1989 holding.
  • Bessemer Group first reported a position in Harmony Biosciences in Q1 2021 and has held it in 19 quarters since.
  • 358 funds tracked by Wall St. Rank held Harmony Biosciences as of Q3 2026.

Based on Bessemer Group's 13F filing for Q3 2026, filed 9 Nov 2026.